Genelux (GNLX) Share-based Compensation (2022 - 2026)

Genelux (GNLX) recorded quarterly Share-based Compensation of $1.4 million in Q1 2026, down 27.55% quarter-over-quarter from $1.9 million in Q4 2025, and down 9.01% on a YoY basis from $1.5 million in Q1 2025.

Genelux (GNLX) Share-based Compensation (2022 - 2026) Analysis & Trends

Genelux's Share-based Compensation history runs 5 years deep, the most recent figure standing at $1.4 million for Q1 2026.

  • In Q1 2026, Share-based Compensation fell 9.01% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $7.4 million (down 12.88% YoY), while the FY2025 annual figure was $7.6 million, down 6.63% from the prior year.
  • Share-based Compensation was $1.4 million for Q1 2026 at Genelux, down from $1.9 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.8 million in Q4 2024 to a low of $43000.0 in Q4 2022.
  • Historically, Share-based Compensation has averaged $1.4 million across 5 years, with a median of $1.5 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Share-based Compensation surged 3465.12% in 2023, then plunged 49.45% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $43000.0 in 2022, then soared by 3465.12% to $1.5 million in 2023, then surged by 148.27% to $3.8 million in 2024, then slumped by 49.45% to $1.9 million in 2025, then fell by 27.55% to $1.4 million in 2026.
  • The last three Share-based Compensation figures came in at $1.4 million (Q1 2026), $1.9 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Genelux 129.36 Mn 129.36 Mn - 1.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.39 Mn
Mar 31, 2026 1.39 Mn
Dec 31, 2025 1.92 Mn
Dec 31, 2025 1.92 Mn
Sep 30, 2025 2.64 Mn
Sep 30, 2025 2.64 Mn
Jun 30, 2025 1.48 Mn
Jun 30, 2025 1.48 Mn
Mar 31, 2025 1.53 Mn
Mar 31, 2025 1.53 Mn
Dec 31, 2024 3.81 Mn
Dec 31, 2024 3.81 Mn
Sep 30, 2024 1.76 Mn
Sep 30, 2024 1.76 Mn
Jun 30, 2024 1.44 Mn
Jun 30, 2024 1.44 Mn
Mar 31, 2024 1.49 Mn
Mar 31, 2024 1.49 Mn
Dec 31, 2023 1.53 Mn
Dec 31, 2023 1.53 Mn